8-KThe WireRoutine
Reg FD Disclosure · Company Update
Filed Jun 4, 2026 · 25d ago · Accession 0001193125-26-257430
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- AN2 Therapeutics, Inc.
- Ticker
- ANTX
- CIK
- 1880438
- Form type
- 8-K
- Filing date
- Jun 4, 2026
- Report date
- Jun 4, 2026
- Document
- d247428d8k.htm
- Size
- 187 KB